SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending due to a combination of an SEC filing revealing updated change-of-control agreements for senior management, which investors are interpreting as preparation for a potential buyout, and intense short-covering pressure fueled by high borrow fees. The community is actively discussing the stock's positioning ahead of upcoming clinical milestones, with many long-term shareholders expressing conviction in the company's oncology platform while short sellers face significant volatility.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending as it secures critical DOJ clearance for its acquisition of Warner Bros. Discovery, signaling a major milestone for the media conglomerate despite ongoing scrutiny from state attorneys general and international regulators. Community sentiment is heavily focused on the stock's long-term potential following the merger, with many investors debating the impact of integration efforts, regulatory hurdles, and management's strategy to compete with streaming giants.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is experiencing heightened volatility as investors weigh the impact of an Iran peace deal on safe-haven demand against shifting expectations for Federal Reserve interest rate policy. Community sentiment is deeply polarized, with active debates centered on whether recent price corrections represent a structural long-term entry point for gold or a bearish breakdown fueled by a strengthening dollar and shifting inflationary pressures.

Bank of Montreal engages in the provision of banking and financial services to individuals and institutions. It operates through the following segments: Canadian Personal and Commercial Banking (Canadian P&C), United States Personal and Commercial Banking (U.S. P&C), BMO Wealth Management, BMO Capital Markets, and Corporate Services. The company was founded by Robert Armour, John C. Bush, Austin Cuvillier, George Garden, Horatio Gates, James Leslie, George Moffatt, John Richardson and Thomas A. Turner on June 23, 1817 and is headquartered in Montreal, Canada.

Bank of Montreal - MicroSectors Gold Miners 3X Leveraged ETN

GDXU is experiencing significant volatility driven by market debates over Federal Reserve interest rate policy and economic uncertainty, as investors react to the aggressive price swings of gold and mining stocks. Community members are actively debating the sustainability of this leveraged ETN, with many weighing the risks of volatility decay against the potential for large gains during bullish gold cycles.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

GDX is trending as investors weigh potential rate policies and geopolitical tensions, with many in the community closely monitoring institutional inflows as a signal for the next leg of the bull cycle. Discussions are heavily focused on the disconnect between spot prices and miner performance, with traders debating whether current pullbacks represent a long-term entry point amidst global reserve diversification and rising debt concerns.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys is gaining significant momentum as investors track its strategic role in building a domestic U.S. supply chain for critical heavy rare earth elements ahead of upcoming defense procurement mandates. The community is heavily focused on the company's recent partnership agreements, pending financing milestones, and potential index inclusion, viewing the stock as a key long-term play against global supply dependencies.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc. is seeing heightened investor attention as the sector benefits from recent government-backed initiatives and institutional interest in photonic technology. The community is actively debating the company's valuation against its substantial cash position while monitoring recent acquisition news that aims to accelerate its transition to scalable commercial production.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is currently trending as investors weigh conflicting signals from ongoing geopolitical tensions in the Middle East and the upcoming transition to Fed Chair Kevin Warsh. The community is actively debating the potential for rate hikes, with many traders closely monitoring long-term bond yields and inflation expectations as the primary drivers for price direction.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Two Interactive is experiencing heightened market activity as investors react to the confirmed November release date for Grand Theft Auto VI and the upcoming launch of pre-orders. While some in the community debate the company's digital-only strategy and guidance, bullish sentiment remains centered on the game's potential to drive record-breaking long-term earnings.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio Inc (IBRX) is trending as investors weigh the potential for a Russell 1000 index inclusion, which could trigger significant passive fund buying pressure and impact share availability. Community discussion is dominated by debates over institutional positioning, expectations for upcoming catalysts in July, and frustration regarding FDA approval timelines for Anktiva.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aquestive Therapeutics (AQST) Moves 6.6% Higher: Will This Strength Last?

Aquestive Therapeutics (AQST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Ardelyx Stock Up 70%: What to Know About This $490,000 Insider Transaction

Key PointsAccording to an SEC filing, an executive at Ardelyx reported selling 81,898 directly held Common Stock shares on June 18, 2026, generating a transaction value of $490,000...

ARDX Edges Up After Hours On IBSRELA Momentum And Profitability ‘Right Around The Corner’

Equity

CFO said at a conference that profitability is “right around the corner,” though the company is waiting for more top-line certainty before formal guidance.


Should You Buy Ardelyx (ARDX)?

Ardelyx (NASDAQ:ARDX) Trading Up 7.4% - What's Next?

Ardelyx (NASDAQ:ARDX) Shares Up 7.4% - What's Next...

FY2030 Earnings Forecast for Ardelyx Issued By HC Wainwright

Ardelyx, Inc. (NASDAQ:ARDX - Free Report) - Research analysts at HC Wainwright cut their FY2030 earnings per share estimates for Ardelyx in a research note issued on Friday, May 1st. HC Wainwright analyst M. Caufield now anticipates that the biopharmaceutical company will earn $1.60 per share for th...

AIGH Capital Management LLC Purchases 951,500 Shares of Ardelyx, Inc. $ARDX

AIGH Capital Management LLC lifted its position in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 479.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,150,000 shares of the biopharmaceutical company's...

Ardelyx (NASDAQ:ARDX) Shares Gap Down After Earnings Miss

Ardelyx (NASDAQ:ARDX) Shares Gap Down Following Weak Earnings...

Ardelyx (NASDAQ:ARDX) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS

Ardelyx (NASDAQ:ARDX - Get Free Report) issued its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.15) earnings per share for the quarter, missing the consensus...

Ardelyx (ARDX) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Neutral Sentiment

$UBER only

$INTC only

Both $UBER and $INTC

Neither

Nancy Pelosi recently disclosed trades in both Uber ($UBER) and Intel ($INTC) - are you following her into either? Cast your vote below.

Are you following Nancy Pelosi into her latest trades - Uber ($UBER) and Intel ($INTC)?

Feed

News

Sentiment

Earnings

Fundamentals

Info

ARDXArdelyx Inc

Fundamentals

Latest ARDX News